The European Society
of Human Genetics

DNA Day 2016

Prizes

First Place Winner: EUR 300.-
In addition, sponsoring teachers of first place students will receive EUR 1.000.- to organise a science project or to purchase classroom equipment.

Second Place Winner: EUR 200.-
In addition, sponsoring teachers of first place students will receive EUR 800.- to organise a science project or to purchase classroom equipment

Special Commendation by the Jury: EUR 100.-
In addition, sponsoring teachers of first place students will receive EUR 500.- to organise a science project or to purchase classroom equipment

All participants will receive a certificate of appreciation for their participation in the contest.

DNA-DAY 2016 - ESSAY CONTEST

Ninth Annual European DNA Day Essay Contest for High School Students

The Winners have been selected!

The European Society of Human Genetics was delighted that students from 19 European countries submitted 189 essays this year. The evaluation was made involving 58 experts in the field, who selected the following 3 winners and 5 honourable mentions.

The names of the winners (and those who received commendation and honourable mentions) will be announced in front of more than 3.000 international scientists and doctors attending the European Human Genetics Conference in Barcelona on May 24, 2016.

Winners, commendation as well as honourable mentions will receive a diploma within the next weeks. Acknowledgements will be sent to all submitters.

The "Downloads"-section of website will be updated shortly with memorable quotes.

Congratulations to the winners of the 2016 DNA Day Essay contest!

1st Place

Maria Sasaki 
Teacher: Magdalena Mihai 

Cambridge School of Bucharest, Bucharest, Romania  

View Essay

2nd Place

Roberta Caviglioli 
Teacher: Anna Barberis 

Liceo Classico Statale "Andrea D'Oria", Genova, Italy 


View Essay
 
 

3rd Place

Elisabetta De Felice
Teacher: Anna Piseri 

Liceo Classico Tito Livio, Milano, Italy 

View Essay

Honourable Mentions (in alphabetical order)

Sam Blanc
Teacher: Christelle Marecaux 

Lycée Les Eaux Claires, Grenoble, France 

View Essay


Antonia Buongiorno 
Liceo Linguistico V.Gioberti, Torino, Italy

View Essay


Jonas Cerneckis
Teacher: Alyda Daulenskiene 
Vilnius Lyceum, Vilnius, Lithuania  

View Essay


Matija Pecnik 
Teacher: Bernarda Devetak 

II.gimnazija Maribor, Maribor, Slovenia 

View Essay


Sandro Surmava
Teacher: Lali Jibladze 

Tbilisi Green School, Tbilisi, Georgia 

View Essay


Are you one of the winners and there is no picture of you? Then send us your picture to:
contest(at)dnaday.eu 

Questions 2016

One of the following questions had to be answered:

1. Choose a genetic test that is currently available for a condition or disease that does not cause symptoms until adulthood (i.e., an adult-onset condition such as hereditary breast cancer). Describe how the test works and how certain the test results are.
Then, either defend or refute the recommendation below from ESHG on  "Genetic testing in asymptomatic minors”
:   
"Presymptomatic and predictive genetic testing of minors for conditions with adult-onset is acceptable only if preventive actions (e.g. preventive surgery or early detection aimed at therapeutic interventions) can be initiated before adulthood. Otherwise pre symptomatic and predictive genetic testing in minors for adult-onset disorders should be deferred until the person has the maturity and competence to understand the nature of the decision and its implications." 

or

2. Genomics is one of the main technologies that will facilitate personalized (or precision) medicine. In order to maximize the potential for personalized medicine, many people now advocate a big data approach. The future they see is that data from individuals held in  electronic medical records, may be coupled with other information from wearable sensors as well as their biological samples held in DNA biobanks.  Do you agree that the collection of biological samples from entire populations in large biobank facilities is a good idea to better understand the link between genomic markers and correct prevention/curative treatment? Is this the future of personalized medicine or do you see arguments not to share private information so widely?